Insider Trading History of Neurocrine Biosciences Inc

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Neurocrine Biosciences Inc since 2015. This trader's CIK number is 914475. At the time of last reporting, Neurocrine Biosciences Inc was the 10% Owner of Voyager Therapeutics, Inc.. (stock ticker symbol VYGR). Also see all insider trading activities at Voyager Therapeutics, Inc..

Note that in the past NEUROCRINE BIOSCIENCES INC also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Neurocrine Biosciences Inc (NBIX) by Neurocrine Biosciences Inc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 NBIX 0 $0 0 $0 15,000 $71,400

Yearly summary of insider trading at Voyager Therapeutics, Inc. (VYGR) by Neurocrine Biosciences Inc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 VYGR 4,395,588 $39,032,821 0 $0 0 $0
2019 VYGR 4,179,728 $50,002,086 0 $0 0 $0


Insider trading activities at 2 companies by Neurocrine Biosciences Inc:

1. Neurocrine Biosciences Inc (NBIX)

2. Voyager Therapeutics, Inc. (VYGR)

Table 1. Insider trading of Neurocrine Biosciences Inc (NBIX) by Neurocrine Biosciences Inc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-04-07 NBIX Option Ex 15,000 4.76 71,400

Table 2. Insider trading of Voyager Therapeutics, Inc. (VYGR) by Neurocrine Biosciences Inc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-02-23 VYGR Buy 4,395,588 8.88 39,032,821
2019-03-12 VYGR Buy 4,179,728 11.96 50,002,086

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Neurocrine Biosciences Inc (10% Owner of Voyager Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.